Literature DB >> 20180022

Involvement of anion exchanger-2 in apoptosis of endothelial cells induced by high glucose through an mPTP-ROS-Caspase-3 dependent pathway.

Qi-Ren Huang1, Qing Li, Yuan-Hong Chen, Li Li, Li-Li Liu, Shui-Hong Lei, He-Ping Chen, Wei-Jie Peng, Ming He.   

Abstract

Excess apoptosis of endothelial cells (EC) plays crucial roles in the onset and progression of vasculopathy in diabetes mellitus. Anion exchanger-2 (AE2) might be involved in the vasculopathy. However, little is known about the molecular mechanisms that AE2 mediated the apoptosis of EC. The purpose of this study was to explore the role of AE2 in the apoptosis of HUVECs induced by high glucose (HG) and its possible mechanisms. First, HUVECs were exposed to different glucose concentrations (5.5, 17.8, 35.6, 71.2 and 142.4 mmol/l, respectively, pH = 7.40) for different time points (12, 24, 48, 72, 120, and 168 h, respectively). Intracellular Cl(-) concentration ([Cl(-)]i), AE2 expression and the apoptosis were assayed. Then, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), Cl(-)-free media or specific RNA interference (RNAi) for AE2 was used to confirm whether AE2 could mediate the apoptosis induced by HG. Finally, the mechanisms of the AE2-mediated apoptosis were investigated by detecting mitochondrial permeability transition pore (mPTP, DeltaPsim) openings, reactive oxygen species (ROS) levels and Caspase-3 activity. We found that HG upregulated the AE2 expression and activity, increased [Cl(-)]i and induced the apoptosis in a time- and concentration-dependent manner. The apoptosis of HUVECs by HG was possibly mediated by AE2 through an mPTP-ROS-Caspase-3 dependent pathway. These findings suggested that AE2 was likely to be a glucose-sensitive transmembrane transporter and a novel potential therapeutic target for diabetic vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180022     DOI: 10.1007/s10495-010-0477-9

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  8 in total

1.  VDAC: old protein with new roles in diabetes.

Authors:  Koh Sasaki; Reshma Donthamsetty; Michael Heldak; Young-Eun Cho; Brian T Scott; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-12       Impact factor: 4.249

Review 2.  Mitochondrial function in vascular endothelial cell in diabetes.

Authors:  Meenal Pangare; Ayako Makino
Journal:  J Smooth Muscle Res       Date:  2012

3.  Mechanisms of chloride in cardiomyocyte anoxia-reoxygenation injury: the involvement of oxidative stress and NF-kappaB activation.

Authors:  D Liu; H He; G L Li; J Chen; D Yin; Z P Liao; L Tang; Q R Huang; Z F Lai; M He
Journal:  Mol Cell Biochem       Date:  2011-05-08       Impact factor: 3.396

4.  Hyperglycemia as a Risk Factor of Ischemic Stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Honglian Shi
Journal:  J Drug Metab Toxicol       Date:  2013-06-29

5.  Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivo.

Authors:  Hucheng Chen; Jiyu Xu; Yuan Lv; Ping He; Chunyan Liu; Jie Jiao; Shiwei Li; Xuhua Mao; Xue Xue
Journal:  Mol Med Rep       Date:  2018-09-25       Impact factor: 2.952

6.  Trans-repression of NFκB pathway mediated by PPARγ improves vascular endothelium insulin resistance.

Authors:  Ying Kong; Yan Gao; Dongyi Lan; Ying Zhang; Rixin Zhan; Meiqi Liu; Zhouan Zhu; Guohua Zeng; Qiren Huang
Journal:  J Cell Mol Med       Date:  2018-11-05       Impact factor: 5.310

Review 7.  Role of SLC4 and SLC26 solute carriers during oxidative stress.

Authors:  Alessia Remigante; Sara Spinelli; Michael Pusch; Antonio Sarikas; Rossana Morabito; Angela Marino; Silvia Dossena
Journal:  Acta Physiol (Oxf)       Date:  2022-03-01       Impact factor: 7.523

8.  Aconitine induces apoptosis in H9c2 cardiac cells via mitochondria‑mediated pathway.

Authors:  Xiangting Gao; Xincai Zhang; Jun Hu; Xuehua Xu; Yuanyi Zuo; Yun Wang; Jingfeng Ding; Hongfei Xu; Shaohua Zhu
Journal:  Mol Med Rep       Date:  2017-10-26       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.